Management

Kim Arvid Nielsen

Kim Arvid Nielsen is a certified medical doctor from University of Copenhagen and he holds an E*MBA from SIMI. He has for the past 25 years been working in the pharma and biotech industry. First in companies like Pharmacia, Merck-Serono, Ferrosan and Bayer as Country Manager, Vice President and Head of Marketing and the past 15 years in Danish and international biotech start-up companies like Pharmion, Basilea and Serendex as CEO.As CEO for Serendex Kim Arvid Nielsen was responsible for the company's IPO, subsequent delisting and successful merger with the US-based biotech company Savara Inc.Kim Arvid Nielsen has been a member of the Board of Directors at several biotech companies.
Position CEO since 2017
Year of Birth 1959
Holding of shares in Cytovac AB
(as of Dec 31, 2018)
3000
Other ongoing assignments Kim Nielsen does not have other assignments.
Previous Assignments (within the last 5 years) Kim Arvid Nielsen was responsible for the company's IPO, subsequent delisting and successful merger with the US-based biotech company Savara Inc.Kim Arvid Nielsen has been a member of the Board of Directors at several biotech companies.
Independent in relation to the company and its management Yes
Independent in relation to larger shareholders Yes


Error, cant find that post.